{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:30:53Z","timestamp":1776702653833,"version":"3.51.2"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yebeh.2026.110972","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:21:07Z","timestamp":1773217267000},"page":"110972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effectiveness and safety of perampanel in patients with lennox-gastaut syndrome: a single-arm meta-analysis with meta-regression and sensitivity analyses"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3447-0704","authenticated-orcid":false,"given":"Amanda Alves","family":"Rabelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia Fraga Castro e","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmim de Souza","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Alves","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Correa de","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela das Gra\u00e7as dos Santos","family":"Carolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard J.","family":"Steinhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yebeh.2026.110972_b0005","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/epi.17241","article-title":"International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Specchio","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.110972_b0010","series-title":"FYCOMPA (perampanel) \u2013 prescribing information","author":"Catalyst Pharmaceuticals, Inc.","year":"2023"},{"key":"10.1016\/j.yebeh.2026.110972_b0015","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-04414-2","article-title":"Effectiveness and safety of perampanel in Lennox\u2013Gastaut syndrome: a GRADE-assessed systematic review and meta-analysis","author":"Kumar","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"9","key":"10.1016\/j.yebeh.2026.110972_b0020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement","volume":"89","author":"Moher","year":"2009","journal-title":"Phys Ther"},{"key":"10.1016\/j.yebeh.2026.110972_b0025","series-title":"Cochrane handbook for systematic reviews of interventions version 6.5","author":"Higgins","year":"2024"},{"key":"10.1016\/j.yebeh.2026.110972_b0030","series-title":"The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2021"},{"key":"10.1016\/j.yebeh.2026.110972_b0035","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110972_b0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/ane.12781","article-title":"Behavioural changes in patients with intellectual disability treated with perampanel","volume":"136","author":"Andres","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2026.110972_b0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2017.05.036","article-title":"Use of perampanel in children and adolescents with Lennox-Gastaut syndrome","volume":"74","author":"Auvin","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2026.110972_b0050","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0035-1546276","article-title":"Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences","volume":"46","author":"B\u00edr\u00f3","year":"2015","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2026.110972_b0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.seizure.2019.12.024","article-title":"The efficacy of perampanel in young children with drug-resistant epilepsy","volume":"75","author":"Chang","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.110972_b0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2019.12.012","article-title":"Open-label, uncontrolled retrospective study of perampanel in adults with Lennox-Gastaut syndrome","volume":"75","author":"Crespel","year":"2020","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110972_b0065","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/children10061071","article-title":"Efficacy and safety of perampanel in children with drug-resistant focal-onset seizures: a retrospective review","volume":"10","author":"Elmardenly","year":"2023","journal-title":"Children"},{"key":"10.1016\/j.yebeh.2026.110972_b0070","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yebeh.2018.06.033","article-title":"Efficacy and tolerability of perampanel in children and adolescents with pharmacoresistant epilepsy: the first real-world evaluation in Asian pediatric neurology clinics","volume":"85","author":"Lin","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110972_b0075","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/epi.17601","article-title":"Long-term effectiveness of add-on perampanel in patients with Lennox\u2013Gastaut syndrome: a multicenter retrospective study","volume":"64","author":"Matricardi","year":"2023","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2026.110972_b0080","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/epi.17530","article-title":"Perampanel as precision therapy in rare genetic epilepsies","volume":"64","author":"Nissenkorn","year":"2023","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2026.110972_b0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/08830738211047665","article-title":"PROVE-Phase IV study of perampanel in real-world clinical care of patients with epilepsy: interim analysis in pediatric patients","volume":"37","author":"Segal","year":"2022","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1016\/j.yebeh.2026.110972_b0090","first-page":"2084","article-title":"A 3.5-year clinical experience with perampanel for refractory epilepsy","volume":"28","author":"Bin Teni","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.yebeh.2026.110972_b0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/epi.18193","article-title":"Efficacy and safety of perampanel in patients with seizures associated with Lennox\u2013Gastaut syndrome: a randomized trial","volume":"66","author":"Vossler","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.110972_b0100","doi-asserted-by":"crossref","first-page":"30051","DOI":"10.1038\/s41598-024-82014-5","article-title":"Perampanel reduces seizure frequency in patients with developmental and epileptic encephalopathy for a long term","volume":"14","author":"Yamagishi","year":"2024","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.yebeh.2026.110972_b0105","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1007\/s00415-024-12416-y","article-title":"Efficacy and safety of adjunctive perampanel treatment in pediatric patients with epilepsy aged 4\u201312 years: a real-world study","volume":"271","author":"Zeng","year":"2024","journal-title":"J Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:34:33Z","timestamp":1776699273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026000934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":21,"alternative-id":["S1525505026000934"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110972","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of perampanel in patients with lennox-gastaut syndrome: a single-arm meta-analysis with meta-regression and sensitivity analyses","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110972"}}